News

WOONSOCKET, R.I. & TORONTO–(BUSINESS WIRE)–Abacus Health Products, Inc. (CSE: ABCS, OTCQB:ABAHF) (“Abacus”) is pleased to announce that, at the special meeting (“Meeting”) of its shareholders (“Shareholders”) held today, Shareholders approved the acquisition of Abacus by Charlotte’s Web Holdings, Inc. (“Charlotte’s Web”) pursuant to an arrangement (the “Arrangement”) under the Business Corporations Act (Ontario). To be…

Zoned Properties to Expand Arizona Portfolio with Significant Tenant

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Zoned Properties® (OTCQB: ZDPY), a strategic real estate development firm whose primary mission is to provide real estate and sustainability services for the regulated cannabis industry, positioning the company for property acquisitions and revenue growth, today announced that it has finalized a set of lease amendments with its Significant Tenant in Arizona that…

FSD Pharma Inc. Announces C$10.125 Million Private Placement

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (“FSD Pharma” or the “Company”), today announced it has entered into definitive agreements with certain institutional investors for the purchase and sale of 1,500,000 shares of the Company’s Class B Subordinate Voting Shares (“Shares”) at a price of C$6.75 per Share pursuant to a private placement resulting in gross…

Cresco Labs Announces Conference Participation in June 2020

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, today announced its participation in the following conferences: About Cresco Labs Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States. Cresco is built to become the most…

Devonian Health Group Announces an Exclusive Strategic Alliance with CannTx Life Sciences for the development of Cannabinoid-based Pharmaceutical Drugs.

QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical company, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today announced a Strategic Alliance with CannTx Life Sciences Inc. (“CannTx”), a privately-owned cannabis producer licensed by Health Canada under the Cannabis Act. Under the…

REPEAT/Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has entered into an exclusive strategic partnership with Terphogz™, LLC (“Zkittlez™”) to develop and commercialize new and unique cannabis genetics in Oregon. Background & Partnership Highlights Terphogz, LLC is a renowned cannabis breeding group…

Halo Labs Announces Partnership with Zkittlez™ Providing Award Winning Genetics in Oregon

POSaBIT Welcomes Mike Apker as Board Director

SEATTLE–(BUSINESS WIRE)–POSaBIT is pleased to welcome Mike Apker to its board, where he will serve as Board Director. Mr. Apker brings a lifetime of experience and insight to the POSaBIT team. Mike was founder and CEO of Oberon Financial Technology, an investment management software company which was later acquired by Envestnet, Inc. He recently retired…

SOL Global Announces Update to Normal Course Issuer Bid for Purchase of 5% of Company’s Common Shares

TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is pleased to announce that it has purchased an aggregate of 551,000 common shares in the capital of the Company (“Common Shares”) during the current purchase cycle pursuant to the Company’s previously announced normal course issuer bid (“NCIB”), which…

SiteOne Landscape Supply to Participate in the William Blair Growth Stock Virtual Conference

ROSWELL, Ga.–(BUSINESS WIRE)–SiteOne® Landscape Supply, Inc. (NYSE: SITE), announced today that Doug Black, Chairman and Chief Executive Officer; John Guthrie, Executive Vice President, Chief Financial Officer; and Scott Salmon, Executive Vice President, Strategy and Development, will be participating in William Blair’s 40th Annual Growth Stock Conference on June 9, 2020. Management is scheduled to present…

CB Therapeutics Achieves Another Breakthrough with the Biosynthesis of DMT and Related Tryptamine-based Compounds

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics, Inc. has achieved the first successful biosynthesis of DMT (N,N Dimethyltryptamine) and related tryptamine-based compounds in yeast and has filed a patent on their biosynthetic production process for DMT and related analogs. CB Therapeutics’ development of a DMT production process, and its patent application, closely follows the first biosynthetic production of…

Calyxt’s High Oleic Low Linolenic Soybean Oil Deemed Non-Regulated by USDA

ROSEVILLE, Minn.–(BUSINESS WIRE)–Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that its high oleic low linolenic (HOLL) soybean has been deemed a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service (APHIS), an agency of the United States Department of Agriculture (USDA).…